The interaction of serum folate and estradiol levels in Alzheimer's disease

Neuroendocrinology Letters

Volumn 23, Issue 2, 2002, Pages 155-160

  Hogervosrt, Eva ^a   Smith, A David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's dementia; Estradiol; Estrone; Serum folate; SHBG; Testosterone

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; ESTROGEN; ESTRONE; FOLIC ACID; HOMOCYSTEINE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN PROTECTION; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; HUMAN; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSE; MULTIPLE REGRESSION; PREDICTION; SMOKING; VITAMIN SUPPLEMENTATION;

EID: 0036261373     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications
2. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease
3. Effects of estrogen on cognition, mood, and cerebral blood flow in AD
4. Estrogen for Alzheimer's disease in women
5. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease
6. Endogenous sex hormone levels in postmenopausal women with AD
7. Women with dementia of Alzheimer's type have higher levels of estradiol than healthy controls: Prize winning poster
8. Pharmacokinetic and pharmacologic variation between different estrogen products
9. Variations of sex hormone-binding globulin in thyroid dysfunction
10. The influence of smoking on the risk of Alzheimer's disease
11. Pemphigus vulgaris: Environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire
12. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: A placebo-controlled double-blind study
13. Folate, vitamin B12 and serum homocysteine as candidate risk factors for confirmed Alzheimer's disease
14. Alzheimer disease: Protective factors
15. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women
16. Homocysteine: An emerging age-related cardiovascular risk factor
17. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma
18. Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity
19. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
20. Consortium to Establish a Registry for Alzheimer's Disease (CERAD) II. Standardization of the neuropathologic assessment of Alzheimer's disease
21. CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly
22. Apolipoprotein E genotyping by one-stage PCR
23. Analytical evaluation of the testosterone assay on the Bayer Immuno 1 system
24. Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: Optimization of therapeutic dose and route
25. Fully automated fluorescence assay for determining total homocysteine in plasma
26. Evaluation of novel assays in clinical chemistry: Quantification of plasma total homocysteine
27. Brain oestradiol and testosterone levels in Alzheimer's disease
28. Gonadal function in young women with Down syndrome
29. Elevated gonadotropin levels in patients with AD
30. Characteristic plasma hormone changes in Alzheimer's disease
31. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in AD
32. Dexamethasone effects on cortisol secretion in AD
33. Inhibition of the preovulatory prolactin surge in the rat by catechol estrogens: Functional and temporal specificity
34. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk
35. An association of elevated serum gonadotropin concentrations and Alzheimer Disease?
36. Homocysteine, B vitamins, and cognitive deficit in the elderly
37. Plasma homocysteine in women taking hormone replacement therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
38. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
39. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women